News

In its interlocutory judgement of 25 November 2015 in the case Sun Pharmaceutical Industries (Europe) B.V. v. Novartis et al.the District Court of The Hague ruled that Sun has not indirectly infringed Novartis’ second medical use patent EP 1 2 96 689 (EP ‘689) relating to the treatment of osteoporosis. With its judgment, the District

In his decision of 30 March 2016 in the matter Novartis AG v Teva Nederland B.V. et al., the Provisions Judge of the District Court in The Hague held that Novartis is entitled to a Paediatric Extension for Glivec® (imatinib), based on Supplementary Protection Certificate no. 300086. The Provisions Judge has provisionally prohibited Teva to